Your search for apixaban returned 8 results

Older patients, females, and those with comorbidities were more likely to be on multiple medications.

This is an investigational use for Eliquis.

Researchers conducted a post hoc analysis of the ARISTOTLE trial which included patients with atrial fibrillation (AF) and a risk of stroke treated with either apixaban or warfarin for the prevention of stroke/ systemic embolism.

Apixaban is a substrate of P-glycoprotein and P-glycoprotein inhibition increases drug exposure.

The researchers searched the U.S. Medicare database for NVAF patients 65 years of age and older who were newly prescribed one of the following medications: apixaban, dabigatran, rivaroxaban, or warfarin.

ANNEXA-4 is a global, single-arm, open-label clinical trial designed to evaluate andexanet alfa in patients who present with an acute major bleed while receiving apixaban, rivaroxaban, edoxaban or enoxaparin.

End-stage renal disease patients on dialysis with atrial fibrillation are at high risk for thrombotic complications.

The 28-year-old male patient presented with acute-onset vertigo, nausea, vomiting, and unsteady gait.